Insights
Insights
KPMG reports, M&A trends, and owner exit stories — read the market with our specialists.
From USD 5.18 Billion to USD 11.74 Billion — Femtech Reshapes the Women's Health Economy
Femtech — connecting the full life cycle of women's health through data and technology — is growing rapidly. According to Samjong KPMG Economic Research Institute's Samjong Focus, citing Statista, the global femtech market is forecast to grow from USD 5.18 billion in 2023 to USD 11.74 billion by 2029 (CAGR 14.6%). Femtech is evolving into a high-value, integrated industry as AI wearables, personalized monitoring, and end-to-end care solutions mature across menstrual and sexual health, pregnancy and fertility, menopause, and women-specific disease and cancer management.
Structural drivers of market growth. Three forces underpin femtech's growth. First, the rising economic power and labor-market participation of women is accelerating health-related spending. Second, AI-driven wearables and life-cycle data platforms are dramatically expanding the addressable service area. Third, the Gates Foundation announced in August 2025 a USD 2.5 billion commitment to women's health research through 2030, and policy support in the US and Europe is intensifying. In Korea, the Korea Femtech Industry Council launched in December 2025, kicking off ecosystem building for K-Femtech.
Business trends: B2B2C and integrated platforms. Major global femtech firms are shifting from B2C app-centric models toward B2B2C structures via partnerships with employers, insurers, and hospitals. In IVF and other fertility-treatment areas, AI robotics adoption is accelerating, while IoT-based smart rings and wearables are becoming critical infrastructure for precision medicine by enabling real-time data collection.
What this means for M&A. Femtech's structural growth is creating M&A opportunities for healthcare and tech alike. First, traditional healthcare and insurance companies are likely to accelerate bolt-on acquisitions of femtech startups to internalize digital women's health capabilities. Second, global firms may use the Korean market — where entry barriers in certain life-cycle segments are low — as a beachhead, expanding cross-border partnerships and investments with K-Femtech players. Third, platforms holding life-cycle-spanning data are emerging as core assets in precision and predictive healthcare, and are likely to command sizeable valuation premiums.
---
Full report: Samjong KPMG Economic Research Institute, Samjong Focus (March 2026)
Contact: Samjong KPMG M&A Center